ArticleFrontiers in oncology2026

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells.

Ryuta Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.